Leflox IV Infusion

Leflox IV Infusion – High-Potency Injectable Antibiotic

Leflox IV is an injectable fluoroquinolone antibiotic formulated for the treatment of severe bacterial infections in clinical or hospital settings. It is utilized when rapid drug delivery is necessary or when the oral route is not feasible. Leflox IV is indicated for adults with mild, moderate, and severe infections across multiple systems, including acute bacterial sinusitis and serious respiratory conditions like community-acquired or nosocomial pneumonia.

The infusion is also highly effective for managing complicated urinary tract infections, acute kidney infections (pyelonephritis), and chronic bacterial prostatitis. Clinically, it treats various skin and skin structure infections and is utilized in the management of inhalational anthrax following exposure. By inhibiting the enzymes required for bacterial DNA replication, it rapidly clears systemic infections. The 500mg/100ml concentration ensures a standardized and effective dose for critical care management.

• Injectable therapy for severe pneumonia and kidney infections.
• Effective against complicated skin and urinary infections.
• Used for post-exposure management of inhalational anthrax.
• Available as: Injectable 500MG/100ML.